BioNTech SE - ADR vs TKO Group Holdings Inc — how do they compare? BioNTech SE - ADR trades at $92.8 (market cap $23.31B), while TKO Group Holdings Inc trades at $194.36 (market cap $14.24B). The key difference: BioNTech SE - ADR is the larger of the two by market cap, and TKO Group Holdings Inc pays a 1.6% dividend while BioNTech SE - ADR pays none. Which is the better fit depends on your goals.
| BNTX | TKO | |
|---|---|---|
Market Cap | $23.31B | $14.24B |
Sector | Health | Technology |
52-Week High | $119.34 | $224.96 |
52-Week Low | $83.89 | $176.49 |
Enterprise Value | $6.60B | $18.60B |
Dividend Yield | — | 1.6% |
Trailing returns across standard periods
BioNTech is a Germany-based biotechnology company that focuses on developing cancer therapeutics, including individualized immunotherapy, as well as vaccines for infectious diseases, including COVID-19. The company's oncology pipeline contains several classes of drugs, including mRNA-based drugs to encode antigens, neoantigens, cytokines, and antibodies.
Read more on BNTX →TKO Group Holdings is a premium sports and entertainment company that serves as the parent entity for the Ultimate Fighting Championship (UFC) and World Wrestling Entertainment (WWE). Formed through a seismic merger orchestrated by Endeavor, TKO leverages a combined global fanbase of over 1 billion to drive massive revenue through media rights, global live events, and a unified sponsorship platform, effectively monopolizing the professional combat sports landscape.
Read more on TKO →